SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-19-001107
Filing Date
2019-02-14
Accepted
2019-02-14 15:15:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 APELLIS PHARMACEUTICALS, INC. p19-0441sc13ga.htm SC 13G/A 43884
  Complete submission text file 0000902664-19-001107.txt   45707
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90187 | Film No.: 19605212
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103
Business Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103 345.749.8642
Hillhouse Capital Management, Ltd. (Filed by) CIK: 0001510589 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A